Back to News

The ISN-ACT Committee Releases Statement to Encourage the Inclusion of Kidney Patients in Research Activities.

The International Society of Nephrology urges all investigators and industry partners to include people with kidney diseases in research activities related to COVID-19.

The ISN-ACT (Advancing Clinical Trials) Committee has released a statement on the urgent need to include patients with kidney diseases in clinical trials related to COVID-19.

Despite preliminary studies demonstrating the increased risk for people with kidney diseases to develop severe COVID-19 symptoms or to die from COVID-19, kidney patients are frequently excluded from COVID-19-related clinical trials. Effective therapies are needed to prevent and treat COVID-19 in all patients, including those with kidney diseases, and to reduce the current burden to healthcare systems.

Help us advance kidney health worldwide
Join the ISN Subscribe to ISN Newsletter
Back to News